Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors

NCT05544240 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer
Metastatic Breast Cancer
Metastatic Lung Cancer
Solid Tumor
Cancer

Interventions

DRUG: SV-101

Sponsor

Williams Cancer Foundation

Collaborators

[object Object]